Medicare Enrolled
Dr. Salil Gabale, M.D.
Surgery · Doylestown, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gabale from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gabale?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gabale
Dr. Salil Gabale is a surgery specialist in Doylestown, PA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Gabale performed 1,382 Medicare services across 1,135 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gabale received a total of $5,709 from 53 pharmaceutical and/or device companies across 243 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgery. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gabale is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 4% volume in PA
$5,709 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,382
Medicare services
Top 4% in PA for surgery
1,135
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~106 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
289 | $92 | $205 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
239 | $3 | $20 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
236 | $8 | $48 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
132 | $71 | $145 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
118 | $123 | $270 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
55 | $129 | $290 |
| New patient office visit, complex (60-74 min) | 51 | $142 | $355 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
50 | $19 | $55 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
41 | $41 | $135 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
24 | $65 | $150 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
17 | $199 | $450 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
17 | $145 | $800 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $106 | $1,500 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
16 | $25 | $270 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
16 | $41 | $120 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $81 | $180 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
14 | $98 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $142 | $300 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
12 | $170 | $550 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
11 | $123 | $700 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.0% high complexity
19.4% medium
78.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,709
Total received (2018-2024)
Avg $816/year across 7 years
Top 22% in PA for surgery
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
243
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,942 (86.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$768 (13.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$971
2023
$727
2022
$745
2021
$844
2020
$386
2019
$1,010
2018
$1,027
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$217
Medtronic, Inc.
$106
Teleflex LLC
$105
Sumitomo Pharma America, Inc.
$84
Blue Earth Diagnostics Limited
$56
PROGENICS PHARMACEUTICALS, INC.
$47
Boston Scientific Corporation
$46
Axonics, Inc.
$44
Tolmar, Inc.
$42
COLOPLAST CORP
$31
Baxter Healthcare
$30
Laborie Medical Technologies Corp.
$30
UROGEN PHARMA, INC.
$30
Astellas Pharma US Inc
$26
Photocure Inc
$22
Endo USA, Inc.
$22
Myriad Genetic Laboratories, Inc.
$17
Merck Sharp & Dohme LLC
$17
Top 3 companies account for 44.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,369
Teleflex LLC
$471
ABBVIE INC.
$419
Dendreon Pharmaceuticals LLC
$375
Endo Pharmaceuticals Inc.
$303
Janssen Biotech, Inc.
$186
NeoTract Inc.
$158
Medtronic, Inc.
$143
Bayer HealthCare Pharmaceuticals Inc.
$141
Blue Earth Diagnostics Limited
$136
180 Medical, Inc.
$130
Boston Scientific Corporation
$127
Olympus America Inc.
$124
Photocure Inc
$113
Sumitomo Pharma America, Inc.
$112
AbbVie Inc.
$101
Janssen Products, LP
$99
Avadel Specialty Pharmaceuticals, LLC
$95
PFIZER INC.
$86
Mission Pharmacal Company
$66
Axonics, Inc.
$61
C. R. Bard, Inc. & Subsidiaries
$56
PROGENICS PHARMACEUTICALS, INC.
$47
DENTSPLY IH AB
$47
Allergan, Inc.
$46
Tolmar, Inc.
$42
Progenics Pharmaceuticals, Inc.
$41
ConvaTec Inc.
$40
Smith+Nephew, Inc.
$38
Myovant Sciences Inc.
$32
BOSTON SCIENTIFIC CORPORATION
$32
Merck Sharp & Dohme LLC
$32
COLOPLAST CORP
$31
Baxter Healthcare
$30
Laborie Medical Technologies Corp.
$30
AbbVie, Inc.
$30
UROGEN PHARMA, INC.
$30
TOLMAR Pharmaceuticals, Inc.
$25
UROVANT SCIENCES INC
$24
Amgen Inc.
$24
Antares Pharma, Inc.
$22
Endo USA, Inc.
$22
Acerus Pharmaceuticals Corporation
$22
Trevena, Inc.
$22
Coloplast Corp
$21
Myriad Genetic Laboratories, Inc.
$17
MEDIVATION FIELD SOLUTIONS LLC
$16
MAYNE PHARMA COMMERCIAL LLC
$16
Ferring Pharmaceuticals Inc.
$14
Telix Pharmaceuticals
$14
Aytu BioScience, Inc
$14
KARL STORZ Endoscopy-America
$12
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 39.6% of all-time payments
Associated products mentioned in payments ›
16 FR. FLEXIBLE VIDEO CYSTOSCOPE · AMS 700 CXR RTE KIT · AVEED · Altis · Androgel · Axonics · Axonics r-SNM System · BOTOX · Bard Urinary Drainage Bag · CYSVIEW · Cysview · ELIGARD · Erleada · FIRMAGON · GEMTESA · GENTLECATH · GRAFIX PL · General - Kidney Stone Disease · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Luja Coude · Lupron · MYRBETRIQ · Myrbetriq · Natesto · Noctiva · ORGOVYX · Olinvyk · Optilume BPH Drug Coated Balloon Catheter · PERCLOT · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolia · SpaceOAR VUE System - 10mL · SpeediCath · URIBEL · UROLIFT · Uribel · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Surgerists within 10 mi
742
Per 100K population
114.9
County median income
$111,951
Nearest hospital
DOYLESTOWN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gabale is a clinical cardiology specialist, with above-average Medicare volume (top 4% in PA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gabale experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gabale performed 289 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gabale receive payments from pharmaceutical companies?
Yes. Dr. Gabale received a total of $5,709 from 53 companies across 243 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gabale's costs compare to other surgerists in Doylestown?
Dr. Gabale's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gabale) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Surgerists in Doylestown
Browse surgerists in Doylestown ranked by procedure volume and transparency data.
Highest volume
Top Surgerists in PA
Surgerists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Surgerists in PA
Which PA surgerists receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology